Publications by authors named "Robert F Storey"

100Publications

A proteomics-based assessment of inflammation signatures in endotoxemia.

Mol Cell Proteomics 2020 Dec 7. Epub 2020 Dec 7.

King's BHF Centre of Research Excellence, Kings College London, United Kingdom

View Article and Find Full Text PDF
December 2020

The cardiac complications of COVID-19: many publications, multiple uncertainties.

Vasc Biol 2020 20;2(1):R105-R114. Epub 2020 Oct 20.

Department of Infection, Immunity and Cardiovascular Diseases, University of Sheffield, Sheffield, UK.

View Article and Find Full Text PDF
October 2020

Antithrombotic therapy for patients with chronic coronary syndromes.

Heart 2020 Oct 30. Epub 2020 Oct 30.

Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK

View Article and Find Full Text PDF
October 2020

The long journey of individualizing antiplatelet therapy after acute coronary syndromes.

Authors:
Robert F Storey

Eur Heart J 2020 Oct;41(37):3546-3548

Cardiovascular Research Unit, Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.

View Article and Find Full Text PDF
October 2020

New Antithrombotic Drugs in Acute Coronary Syndrome.

J Clin Med 2020 Jun 30;9(7). Epub 2020 Jun 30.

Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, UK.

View Article and Find Full Text PDF
June 2020

Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis.

Thromb Haemost 2020 Apr 14;120(4):538-564. Epub 2020 Apr 14.

Laboratory for Clinical Thrombosis and Hemostasis, Department of Biochemistry and Internal Medicine and Thrombosis Expert Center, Maastricht University Medical Center and CARIM School for Cardiovascular Diseases, Maastricht, The Netherlands.

View Article and Find Full Text PDF
April 2020

Pharmacology and potential role of selatogrel, a subcutaneous platelet P2Y receptor antagonist.

Expert Opin Emerg Drugs 2020 03 17;25(1):1-6. Epub 2020 Feb 17.

Cardiovascular Research Unit, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

View Article and Find Full Text PDF
March 2020

Opiates and Clopidogrel Efficacy: Lost in Transit?

J Am Coll Cardiol 2020 01;75(3):301-303

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom; South Yorkshire Cardiothoracic Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.

View Article and Find Full Text PDF
January 2020

Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study.

Thromb Haemost 2020 Mar 23;120(3):412-422. Epub 2020 Jan 23.

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.

View Article and Find Full Text PDF
March 2020

Novel approaches to P2Y inhibition and aspirin dosing.

Platelets 2021 Jan 19;32(1):7-14. Epub 2020 Jan 19.

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield , Sheffield, UK.

View Article and Find Full Text PDF
January 2021

Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: effects on platelet function and cellular adenosine uptake.

Platelets 2020 Oct 2;31(7):945-951. Epub 2020 Jan 2.

Department of Infection, Immunity and Cardiovascular Disease, The Medical School, University of Sheffield , Sheffield, UK.

View Article and Find Full Text PDF
October 2020

ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial.

Atherosclerosis 2020 01 29;293:35-41. Epub 2019 Nov 29.

Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.

View Article and Find Full Text PDF
January 2020

Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?

EuroIntervention 2020 Jan;15(13):1125-1129

Department of Cardiology, Erasmus Medical Center, Thoraxcenter, Rotterdam, the Netherlands.

View Article and Find Full Text PDF
January 2020

Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction.

Platelets 2020 10;31(2):174-178. Epub 2019 Sep 10.

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

View Article and Find Full Text PDF
September 2020

Complete Revascularization with Multivessel PCI for Myocardial Infarction.

N Engl J Med 2019 10 1;381(15):1411-1421. Epub 2019 Sep 1.

From the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON (S.R.M., H.N., B.M., T.S., N.P.-E., J.N., J.W., S.I.B.), the University of British Columbia, Vancouver (D.A.W., J.A.C.), the University of Alberta, Mazankowski Alberta Heart Institute, Edmonton (K.R.B., R.W.), Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City (J.R.-C.), the University of Western Ontario, London Health Sciences Centre, London (S.L.), and the University of Toronto, Toronto Southlake Regional Health Centre, Toronto (W.J.C.) - all in Canada; the Department of Infection, Immunity, and Cardiovascular Disease, University of Sheffield, Sheffield (R.F.S.), the Royal Wolverhampton Hospitals NHS Trust, Wolverhampton (B.W.), the University Clinic of Cardiology, South Tees Hospitals NHS Foundation Trust, Middlesbrough (A.S.), and Hull University Teaching Hospitals NHS Trust, Hull (R.O.) - all in the United Kingdom; the Zena A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York (R.M.); Ospedale Maggiore, Bologna (G.D.P.), the Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona (G.C.), and Maria Cecilia Hospital, GVM Care and Research, Cotignola (G.C.) - all in Italy; University Hospital La Paz, Madrid (J.L.-S., R.M.); Brigham and Women's Hospital and Harvard Medical School, Boston (D.P.F., L.M.); Duke University Medical Center, Durham, NC (S.V.R.); Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris (L.F., P.G.S.); Hospital Alemão Oswaldo Cruz, Instituto Dante Pazzanese de Cardiologia, São Paulo (A.A.); the University Clinic of Cardiology, University St. Cyril and Methodius, Skopje, Macedonia (S.K.); and the Clinical Center of Serbia, Belgrade (G.S.).

View Article and Find Full Text PDF
October 2019

Aspirin and Primary Prevention in Patients with Diabetes-A Critical Evaluation of Available Randomized Trials and Meta-Analyses.

Thromb Haemost 2019 10 20;119(10):1573-1582. Epub 2019 Aug 20.

Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.

View Article and Find Full Text PDF
October 2019

Antithrombotics: From Aspirin to DOACs in Coronary Artery Disease and Atrial Fibrillation (Part 3/5).

J Am Coll Cardiol 2019 08 2;74(5):699-711. Epub 2019 Jul 2.

Duke Clinical Research Institute and Division of Cardiology, Duke University Medical Center, Durham, North Carolina.

View Article and Find Full Text PDF
August 2019

Does Risk of Premature Discontinuation of Dual-Antiplatelet Therapy Following PCI Attenuate With Increasing Age?

JACC Cardiovasc Interv 2019 05;12(10):993-994

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom. Electronic address:

View Article and Find Full Text PDF
May 2019

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.

N Engl J Med 2019 04 17;380(16):1509-1524. Epub 2019 Mar 17.

From the Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (R.D.L., G.H., A.N.V., T.M., C.B.G., J.H.A.); Bristol-Myers Squibb, Princeton, NJ (R.A., J.L.); Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, and Cardiovascular Research Foundation, New York (R.M.); Canadian VIGOUR Centre, University of Alberta, Edmonton (S.G.G.), and the Terrence Donnelly Heart Centre, St. Michael's Hospital, University of Toronto, Toronto (S.G.G.) - both in Canada; Swiss Cardiovascular Center, Bern, Switzerland (S.W.); Vivantes Neukoelln Medical Center, Berlin (H.D.), and Heart Center Leipzig, Department of Internal Medicine-Cardiology, University of Leipzig, Leipzig (H.T.) - both in Germany; Pirogov Russian National Research Medical University, Moscow (O.A.); Instituto de Neurología Cognitiva (INECO) Neurociencias Oroño, Fundación INECO, Rosario, Argentina (M.C.B.); Hospital Israelita Albert Einstein, São Paulo (O.B.); Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); the Department of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden (Z.H.); the National Scientific Center, Strazhesko Institute of Cardiology, Kiev, Ukraine (A.P.); University Hospitals Leuven, University of Leuven, Leuven, Belgium (P.S.); the Department of Infection, Immunity, and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom (R.F.S.); and University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital, Bucharest, Romania (D.V.).

View Article and Find Full Text PDF
April 2019

Combining DAPT with a PPI faces the acid test of real-world use.

Eur Heart J 2019 06;40(24):1971-1974

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

View Article and Find Full Text PDF
June 2019

Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients with Stable Coronary Artery Disease?

Thromb Haemost 2019 10 5;119(10):1583-1589. Epub 2019 Mar 5.

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.

View Article and Find Full Text PDF
October 2019

Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes.

Diabetes Care 2018 12 16;41(12):2625-2633. Epub 2018 Oct 16.

Department of Oncology and Metabolism, University of Sheffield, Sheffield, U.K.

View Article and Find Full Text PDF
December 2018

Response by Angiolillo et al to Letter Regarding Article, "International Expert Consensus Document on Switching Platelet P2Y Receptor Inhibiting Therapies".

Circulation 2018 05;137(21):2310-2311

Department of Infection, Immunity, and Cardiovascular Disease, University of Sheffield, United Kingdom (R.F.S.).

View Article and Find Full Text PDF
May 2018

Dual antiplatelet therapy in the 'real world'.

Heart 2018 10 24;104(19):1555-1556. Epub 2018 Mar 24.

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

View Article and Find Full Text PDF
October 2018

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy.

Eur Heart J 2018 04;39(13):1078-1085

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK.

View Article and Find Full Text PDF
April 2018

The challenges of antithrombotic therapy in patients with left ventricular thrombosis.

Eur Heart J 2018 01;39(3):209-211

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

View Article and Find Full Text PDF
January 2018

Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.

Circulation 2018 02 30;137(7):684-692. Epub 2017 Oct 30.

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (I.C., D.A.M., D.L.B., B.S.S., E.L.G., E.B., M.S.S., M.P.B.)

View Article and Find Full Text PDF
February 2018

Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis.

J Am Coll Cardiol 2017 Oct;70(14):1760-1776

Cardiovascular Science Institute-ICCC IIB-Sant Pau, CiberCV, Hospital de Sant Pau, Barcelona, Spain.

View Article and Find Full Text PDF
October 2017

The IL-1RI Co-Receptor TILRR ( Isoform 2) Controls Aberrant Inflammatory Responses and Development of Vascular Disease.

JACC Basic Transl Sci 2017 Aug 28;2(4):398-414. Epub 2017 Aug 28.

Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.

View Article and Find Full Text PDF
August 2017